/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Mary McCormack

University College Hospital(GB)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

129

Papers

4.1K

Citations

27

h-index

50

i10-index

Mary McCormack is an academic researcher from University College Hospital. The author has contributed to research in topics: Endometrial and Cervical Cancer Treatments & Ovarian cancer diagnosis and treatment & Cervical Cancer and HPV Research. The author has an h-index of 27, co-authored 110 publications.

ORCID: 0000-0002-8429-5744

Research Topics

Endometrial and Cervical Cancer Treatments Ovarian cancer diagnosis and treatment Cervical Cancer and HPV Research Endometriosis Research and Treatment Colorectal and Anal Carcinomas

Papers by this author

works

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

2019 · The Lancet Oncology · 438 citations

https://doi.org/10.1016/s1470-2045(19)30395-x

Stephanie M. de Boer Melanie Powell Linda Mileshkin Dionyssios Katsaros

SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study

2019 · International Journal of Gynecological Cancer · 176 citations

https://doi.org/10.1136/ijgc-2019-000332

Fabrice Lécuru Mary McCormack Peter Hillemanns Amélie Anota

Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial

2024 · The Lancet · 109 citations

https://doi.org/10.1016/s0140-6736(24)01438-7

Mary McCormack Gemma Eminowicz Dolores Gallardo Patricia Díez

Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial

2020 · International Journal of Radiation Oncology*Biology*Physics · 44 citations

https://doi.org/10.1016/j.ijrobp.2020.10.030

Cathalijne Post Stephanie M. de Boer Melanie Powell Linda Mileshkin

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial

2025 · The Lancet Oncology · 18 citations

https://doi.org/10.1016/s1470-2045(25)00379-1

Cathalijne Post Stephanie M. de Boer Melanie Powell Linda Mileshkin

The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries

2021 · International Journal of Gynecological Cancer · 17 citations

https://doi.org/10.1136/ijgc-2021-002422

Mary McCormack David K. Gaffney David S.P. Tan Kathy Bennet

Research topics

topics

Endometrial and Cervical Cancer Treatments

Ovarian cancer diagnosis and treatment

Cervical Cancer and HPV Research

Endometriosis Research and Treatment

Colorectal and Anal Carcinomas

Chat about Author

Papers

Chat

Click to start Chat